Brinton gets nod from DCGI for favipiravir in India

Pharma Company, Brinton Pharmaceuticals has received green signal from Drugs Controller General of India (DCGI) for marketing of favipiravir under the brand name faviton. The drug will be marketed in India and exported globally by the company and will be available in 200 mg tablets.

Favipiravir is an effective treatment option in the management of mild-to-moderate COVID-19 as per clinical evidence. The medicine is an orally-administered medication and more convenient compared to intravenously-administered medicines.

Rahul Kumar Darda, CMD, Brinton Pharmaceuticals, said, “We always wanted to launch “evidence-based cure” to combat COVID-19. Our strategic intent will be to improve the access through our strong distribution network that will help make faviton available across all COVID treatment centres and our MRP is Rs 59 per tablet”.

The drug will be available in a strip of 10 tablets and 50 tablets in a box.

  • Related Posts

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    In a First to India, Maker of Surgical Robot SSiMantra, brings ultimate Laurel New Delhi: Indian Medtech company SS Innovations’ SSiMantra, the best in class only ‘Made in India’ surgical…

    India curbs supply of IVF consumables to unregistered clinics

    The move comes amid growing concerns over the proliferation of fertility centres in India, one of the world’s fastest-growing IVF markets. New Delhi: India is moving to cut off supplies…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility

    India curbs supply of IVF consumables to unregistered clinics

    India curbs supply of IVF consumables to unregistered clinics

    Maha FDA seizes counterfeit skincare products; FIR registered

    Maha FDA seizes counterfeit skincare products; FIR registered

    RMSCL MD Inspects Rajasthan Sampark Portal; Directs Prompt Resolution of Medicine-Related Grievances

    RMSCL MD Inspects Rajasthan Sampark Portal; Directs Prompt Resolution of Medicine-Related Grievances

    4 arrested in blood plasma adulteration racket

    4 arrested in blood plasma adulteration racket